LakeShore Biopharma Co., Ltd: operating_income
| Value | {"amount": -12021382, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2024-04-01 – 2025-03-31 |
| Status | current |
| Entity | LakeShore Biopharma Co., Ltd |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/704b0c41-f955-4fe4-ae45-c2eee524cd01
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-25-069880Retrieved: 2026-08-19T18:58:48.545571+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001946399/operating-income/2025-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/704b0c41-f955-4fe4-ae45-c2eee524cd01
History
- supersedes {"unit": "CNY", "value": -86291884, "concept": "us-gaap:OperatingIncomeLoss"} (evidence 0001213900-25-069880)